StreetInsider.com

New Progress -- XellSmart Unveiled Phase I Results of Off-the-Shelf Parkinson's Disease Cell Therapy at MDS & Completed Blinded Phase II Enrollment

For motor function, participants' OFF-state MDS-UPDRS Part III scores improved by an average of more than 30 points from ...